Gastrointestinal Adverse Effects of Iron Preparations

Introduction to Gastrointestinal Adverse Effects

• Gastrointestinal adverse effects, such as nausea, diarrhea, and constipation, are significantly more common with oral iron preparations than with placebo (OR 2.32) or parenteral iron (OR 3.05) 1
• These side effects occur regardless of dose in the range of 50-400 mg elemental iron per day 1

Diagnosis and Monitoring

• Hemoglobin levels should be checked within 4 weeks of starting therapy, with an expected hemoglobin rise of approximately 2 g/dL after 3-4 weeks, as recommended by the American Gastroenterological Association 2, 1
• Regular monitoring is essential to ensure treatment efficacy, with hemoglobin response checked within 4 weeks of starting therapy, and an Hb rise of at least 10 g/L after 2 weeks predicting successful treatment 1
• Parameters to monitor include hemoglobin, serum ferritin, and transferrin saturation, with an initial frequency of every month in patients not receiving IV iron and every 3 months in patients receiving IV iron 1, 3

Treatment Guidelines

• Oral iron supplementation is recommended as first-line therapy in most patients, according to the American Gastroenterological Association 2
• The initial treatment of iron deficiency anemia should be with one tablet per day of ferrous sulfate (65mg elemental iron), ferrous fumarate, or ferrous gluconate, preferably taken in the morning on an empty stomach, as recommended by the Gut guideline society 1
• The recommended dosing for oral iron supplements is as follows:

1, 4, 5

• Concomitant use of ascorbic acid (vitamin C) at a molar ratio of at least 2:1 to enhance iron absorption is recommended by the American Gastroenterological Association 6, 7
• Treatment should continue for 3 months after hemoglobin normalization to ensure adequate replenishment of marrow iron stores 1

Special Populations

• Patients with inflammatory bowel disease may require higher doses or parenteral iron due to higher rates of intolerance and malabsorption 1
• Pregnant women may require higher doses (30-120 mg/day) 1
• Severe symptomatic anemia may require limited transfusion of packed red cells, but iron replacement therapy is still necessary post-transfusion 1

Parenteral Iron Therapy

• The European Society for Clinical Nutrition and Metabolism recommends intravenous iron for patients with inflammatory bowel disease with active inflammation, patients with previous intolerance to oral iron, patients with hemoglobin below a certain threshold, and patients who need erythropoiesis-stimulating agents 8
• The American Gastroenterological Association suggests using intravenous iron when blood loss exceeds the ability to replete iron orally 2
• Patients with documented iron deficiency anemia and failed oral iron therapy are indicated for intravenous iron therapy, according to the American Gastroenterological Association 2
• The following table summarizes different iron preparations:

• The American Journal of Hematology recommends calculating total iron deficit based on hemoglobin level and body weight, and administering intravenous iron according to specific product guidelines, with maximum doses of 125 mg per dose for Ferrlecit and 200 mg per dose for Venofer 11

Minimizing Adverse Effects

• High-dose iron supplementation increases gastrointestinal side effects, including nausea, constipation, diarrhea, and heartburn, with dropout rates due to adverse effects reaching up to 40% 1
• Alternate-day dosing reduces side effects by allowing gut recovery between doses 1
• Common side effects of oral iron include gastrointestinal symptoms, such as nausea, constipation, diarrhea, heartburn, and dyspepsia, according to the American Society of Hematology 11
• Ferric maltol may be considered for patients with persistent side effects from traditional iron salts (normalizes hemoglobin in 63-66% of cases within 12 weeks) 1